Rapid Risk Assessment: Severe respiratory disease associated with a novel coronavirus
New and noteworthy in this update: the retrospective identification of novel coronavirus in biological samples from two fatal cases in Jordan (April 2012) and the results of a joint ECDC/WHO survey which confirms that EU/EEA Member States have an adequate capacity to detect novel coronavirus through their network of national reference laboratories: 18 of 30 in EU/EEA countries are capable of confirming positive screened samples by either ORF1b RT-PCR or other target RT-PCR assays with sequence analysis or whole-genome sequence analysis.
Rapid risk assessment: Severe respiratory disease associated with Middle East respiratory syndrome coronavirus (MERS-CoV). Eleventh update, 21 August 2014
This eleventh updated rapid risk assessment on MERS-CoV shows that the number of cases has been steadily declining in the last few months.
Severe respiratory disease associated with Middle East respiratory syndrome coronavirus - 21st update, 21 October 2015
This 21st update of ECDC’s risk assessment on MERS-CoV has been triggered by an increase in MERS cases acquired through nosocomial transmission in Amman, Jordan.
Epidemiological update: novel coronavirus, 30 November 2012Archived
On 30 November WHO updated the number of confirmed cases of pneumonia caused by the novel coronavirus which has been temporarily named hCoV-EMC. Between April 2012 and 30 November 2012, nine confirmed cases of infection with the novel coronavirus (of whom five died) have been reported to WHO, according to its case definitions. Severe acute respiratory disease was the common presentation of all cases.
WHO Eastern Mediterranean Region: Influenza updates (EMFLU)
Eastern Mediterranean Flu (EMFLU) is a regional platform for sharing of epidemiological and virological data on influenza in the WHO Eastern Mediterranean Region.